In the intracranial hemorrhage (ICH) model, CBL can ameliorate secondary injury and promote behavioral performance during the acute phase by reducing brain edema, the inflammatory response, and BBB permeability by decreasing the expression levels of IL-1β, TNF-a, IL-6, and AQP4. Here, AQP4 is linked to intracranial hemorrhage.